AgingResearch.NewsJoin free

Anticholinergic and/or sedative medications

Anticholinergic and/or sedative medications has been studied in 1 paper since 2025: 1 observational study in people; 1 in the past year. The newest paper, Nov 6, 2025: “Anticholinergic and sedative medications use among community dwelling older adults: risk for polypharmacy and poor physical function”.

Exposure

1 paper studies it1 findingUpdated

See all 1

“Polypharmacy (p < 0.001) and poor physical function (frailty, p = 0.026; sarcopenia, p = 0.003; instrumental activities of daily living, p = 0.001; and activities of daily living, p = 0.045) were found to be associated with the use of anticholinergic and/or sedative medications”
Anticholinergic and sedative medications use among community dwelling older adults: risk for polypharmacy and poor physical functionBMC geriatrics2025doi:10.1186/s12877-025-06504-5

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Humans1

What is Anticholinergic and/or sedative medications linked with?

1

Studies link Anticholinergic and/or sedative medications with 1 measure, most often polypharmacy (1 study).

Polypharmacy

upin humans1

1 study

  1. Anticholinergic and/or sedative medications are associated with polypharmacy in humans (p < 0.001).

    “Polypharmacy (p < 0.001) and poor physical function (frailty, p = 0.026; sarcopenia, p = 0.003; instrumental activities of daily living, p = 0.001; and activities of daily living, p = 0.045) were found to be associated with the use of anticholinergic and/or sedative medications”

    Humansn = 372

    Anticholinergic and sedative medications use among community dwelling older adults: risk for polypharmacy and poor physical function

    BMC geriatrics

Latest

Related